ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer

Clinical trial NCT02688712 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02688712
Sponsor: Providence Health & Services
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Adenocarcinoma

Start date: 2016-03-24
Primary completion: 2026-01-26
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.